| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6250241 | The Journal of Sexual Medicine | 2010 | 10 Pages |
Abstract
The VR004 system administers low apomorphine doses that are well tolerated without compromising efficacy. This route of administration ensures a rapid onset of action and reproducible efficacy and safety profiles. Inhaled apomorphine is therefore a potential first-line treatment for ED. Riley A, Main M, and Morgan F. Inhalation device allows novel administration of apomorphine in men with erectile dysfunction-efficacy and safety findings.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Alan MBBS, Mark PhD, Frazer BSc (Hons),